Meng-jun Qiu

749 total citations
28 papers, 535 citations indexed

About

Meng-jun Qiu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Meng-jun Qiu has authored 28 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Meng-jun Qiu's work include Ferroptosis and cancer prognosis (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Mechanisms and Therapy (3 papers). Meng-jun Qiu is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Mechanisms and Therapy (3 papers). Meng-jun Qiu collaborates with scholars based in China and United States. Meng-jun Qiu's co-authors include Shengli Yang, Zhifan Xiong, Xiaoxiao He, Zushun Xu, Qiuting Li, Guangfu Liao, Mengmeng Wang, Xiefan Fang, Liping Liu and Yanan Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Meng-jun Qiu

26 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng-jun Qiu China 13 188 174 111 107 102 28 535
Weidong Ni China 13 170 0.9× 189 1.1× 73 0.7× 171 1.6× 73 0.7× 37 603
Li Tu China 14 171 0.9× 218 1.3× 78 0.7× 96 0.9× 60 0.6× 27 580
Rebecca C. Gilson United States 9 254 1.4× 214 1.2× 136 1.2× 90 0.8× 100 1.0× 13 593
Chunjuan Jiang China 14 251 1.3× 127 0.7× 79 0.7× 189 1.8× 113 1.1× 28 587
Xianming Li China 17 184 1.0× 170 1.0× 104 0.9× 133 1.2× 145 1.4× 31 585
Qi Yue China 14 282 1.5× 270 1.6× 75 0.7× 88 0.8× 53 0.5× 32 776
Luwen Zhu China 12 283 1.5× 274 1.6× 92 0.8× 55 0.5× 103 1.0× 18 687
Hongjun Yuan China 15 365 1.9× 220 1.3× 171 1.5× 141 1.3× 128 1.3× 34 818
Yong‐Qu Zhang China 13 231 1.2× 316 1.8× 116 1.0× 158 1.5× 97 1.0× 26 679

Countries citing papers authored by Meng-jun Qiu

Since Specialization
Citations

This map shows the geographic impact of Meng-jun Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-jun Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-jun Qiu more than expected).

Fields of papers citing papers by Meng-jun Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-jun Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-jun Qiu. The network helps show where Meng-jun Qiu may publish in the future.

Co-authorship network of co-authors of Meng-jun Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-jun Qiu. A scholar is included among the top collaborators of Meng-jun Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-jun Qiu. Meng-jun Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xin, Yushuang Xu, Di Chen, et al.. (2022). A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome. SHILAP Revista de lepidopterología. 5 indexed citations
3.
Zhu, Lisheng, Jingyu Liu, Meng-jun Qiu, et al.. (2022). Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma. Biomaterials. 288. 121711–121711. 28 indexed citations
4.
Qiu, Meng-jun, et al.. (2021). Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal–chemodynamic synergistic antitumor therapy. Journal of Materials Chemistry B. 9(42). 8882–8896. 74 indexed citations
5.
Qiu, Meng-jun, Li Zhang, Xiefan Fang, et al.. (2021). Research on the circadian clock gene HNF4a in different malignant tumors. International Journal of Medical Sciences. 18(6). 1339–1347.
6.
Qiu, Meng-jun, Xia Qin, Yaobing Chen, et al.. (2021). The Expression of Three Negative Co-Stimulatory B7 Family Molecules in Small Cell Lung Cancer and Their Effect on Prognosis. Frontiers in Oncology. 11. 600238–600238. 17 indexed citations
7.
Zhu, Lisheng, Tao Ouyang, Ying Xiong, et al.. (2021). Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 714433–714433. 6 indexed citations
8.
Mo, Zhimin, Meng-jun Qiu, Han Hu, et al.. (2021). Multifunctional phototheranostic nanoplatform based on polydopamine-manganese dioxide-IR780 iodide for effective magnetic resonance imaging-guided synergistic photodynamic/photothermal therapy. Journal of Colloid and Interface Science. 611. 193–204. 114 indexed citations
9.
Qiu, Meng-jun, Qiushuang Wang, Qiuting Li, et al.. (2021). KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer. Frontiers in Molecular Biosciences. 8. 559800–559800. 16 indexed citations
10.
Qiu, Meng-jun, Li Zhang, Yaobing Chen, et al.. (2021). KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 137. 106037–106037. 7 indexed citations
11.
Li, Qiuting, et al.. (2020). Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining. Journal of Cancer. 11(9). 2453–2464. 33 indexed citations
12.
He, Xiaoxiao, Qiuting Li, Mengmeng Wang, et al.. (2020). Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by Downregulating MMP‐Related Proteins via Regulation of the NF‐κB Signaling Pathway. BioMed Research International. 2020(1). 3126182–3126182. 12 indexed citations
13.
Qiu, Meng-jun, Xiefan Fang, Qiuting Li, et al.. (2020). Prognosis of primary hepatic lymphoma: A US population-based analysis. Translational Oncology. 14(1). 100931–100931. 10 indexed citations
14.
Li, Qiuting, Meng-jun Qiu, Shengli Yang, et al.. (2020). Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-κB (P65) Pathway in Hepatocellular Carcinoma Cells. Journal of Oncology. 2020. 1–9. 10 indexed citations
15.
Li, Guoquan, Ye Wang, Meng-jun Qiu, et al.. (2020). Optimized CyberKnife Lung Treatment: Effect of Fractionated Tracking Volume Change on Tracking Results. Disease Markers. 2020. 1–8. 1 indexed citations
16.
Wang, Mengmeng, Xiaojuan Qin, Xiaoxiao He, et al.. (2019). Comparison and screening of different risk assessment models for deep vein thrombosis in patients with solid tumors. Journal of Thrombosis and Thrombolysis. 48(2). 292–298. 10 indexed citations
17.
Li, Qiuting, Yiming Feng, Meng-jun Qiu, et al.. (2019). KCNN4 Promotes Invasion and Metastasis through the MAPK/ERK Pathway in Hepatocellular Carcinoma. Journal of Investigative Medicine. 68(1). 68–74. 37 indexed citations
18.
Qiu, Meng-jun, Yaobing Chen, Si Jin, et al.. (2019). Research on circadian clock genes in non-small-cell lung carcinoma. Chronobiology International. 36(6). 739–750. 33 indexed citations
19.
He, Xiaoxiao, Liangliang Shi, Meng-jun Qiu, et al.. (2018). Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families. Biochemical and Biophysical Research Communications. 504(4). 878–884. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026